December 29, 2019
2 min read
Save

Top endocrinology news reports 2019: anti-aging, alternate-day fasting, insulin patch

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In 2019, Healio readers were interested in fertility preservation for men on testosterone therapy, the wonders of metformin, possible associations between statins and diabetes, a new osteoporosis drug and more.

Low-dose hCG can prevent sterility in men prescribed testosterone

Low-dose human chorionic gonadotropin, or hCG, may preserve spermatogenesis in men with hypogonadism treated with intramuscular or transdermal testosterone replacement therapy.

READ

Metformin may hold anti-aging promise to increase ‘health span’

The biguanide metformin, an effective first-line agent for the treatment of type 2 diabetes, has come a long way from the days when the FDA hesitated to approve the drug due to risk for lactic acidosis. Today, metformin, now an inexpensive generic and widely available, has garnered a new reputation as a possible anti-aging wonder pill that influences a host of metabolic and cellular processes closely associated with the development of age-related conditions.

READ

Alternate-day fasting cuts insulin levels, resistance in half

Alternate-day fasting lowered levels of fasting insulin and insulin resistance to a greater degree than calorie restriction among adults with overweight or obesity and insulin resistance.

READ

Insulin patch proves effective for adults with type 2 diabetes

An insulin patch can safely provide similarly effective glycemic management in adults with type 2 diabetes compared with a standard insulin pen.

READ

Statin use raises risks for new-onset diabetes, skin infections

The use of statins for as little as 91 days is associated with an increased risk for skin infections via diabetogenic and nondiabetogenic mechanisms.

READ

Diabetes and fruit 2019 
In 2019, Healio readers were interested in fertility preservation for men on testosterone therapy, the wonders of metformin, possible associations between statins and diabetes, a new osteoporosis drug and more.
Source: Adobe Stock

Exercise and cardiometabolic health: ‘Never too late to start exercising’

Exercise provides important and varied benefits for individuals with cardiometabolic disorders regardless of experience level, and certain exercise types may yield better outcomes for those with certain conditions.

READ

FDA approves romosozumab for osteoporosis

The FDA approved the monoclonal antibody romosozumab to treat osteoporosis in postmenopausal women at high risk for fracture.

READ

Thyroidectomy reduces severe Hashimoto's disease symptoms

For adults with Hashimoto’s disease, total thyroidectomy can reduce symptoms of pain and fatigue that remain even after euthyroid status is achieved with standard medical therapy.

READ

Simultaneous combination therapy shows major potential in type 2 diabetes

When treating patients with type 2 diabetes, physicians may have more success if they use simultaneous combination therapy immediately rather than following the traditional stepped-up method of waiting to intensify treatment.

READ

Supplements, cancer therapies, endocrine-disrupting chemicals can alter thyroid function

Medications, supplements, excessive iodine intake and other exogenous substances including endocrine-disrupting chemicals can influence multiple thyroid effects that clinicians should recognize, including thyroid dysfunction and altered thyroxine absorption.

READ